Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial.

Russell-Jones, David; Babazono, Tetsuya; Cailleteau, Roman; Engberg, Susanne; Irace, Concetta; Kjaersgaard, Maiken Ina Siegismund; Mathieu, Chantal; Rosenstock, Julio; Woo, Vincent; Klonoff, David C

Russell-Jones, David; Babazono, Tetsuya; Cailleteau, Roman; Engberg, Susanne; Irace, Concetta; Kjaersgaard, Maiken Ina Siegismund; Mathieu, Chantal; Rosenstock, Julio; Woo, Vincent; Klonoff, David C.

Affiliation

Russell-Jones D; The Cedar Centre, Royal Surrey Foundation Trust, Guildford, UK; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. Electronic address: davidrussell-jones@nhs.net.
Babazono T; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Cailleteau R; Novo Nordisk, Søborg, Denmark.
Engberg S; Novo Nordisk, Søborg, Denmark.
Irace C; Department of Health Science, University Magna Græcia, Viale Europa, Località Germaneto, Catanzaro, Italy.
Kjaersgaard MIS; Novo Nordisk, Aalborg, Denmark.
Mathieu C; Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.
Rosenstock J; Velocity Clinical Research at Medical City, Dallas, TX, USA.
Woo V; University of Manitoba, Winnipeg, MB, Canada.
Klonoff DC; Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.

Lancet ; 402(10413): 1636-1647, 2023 11 04.

Article in En | MEDLINE | ID: mdl-37863084

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Hypoglycemia Limits: Adult / Humans Language: En Journal: Lancet Year: 2023 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google